Perfect Medical Health Management Limited (HKG:1830)
1.800
+0.020 (1.12%)
Jun 25, 2025, 4:08 PM HKT
HKG:1830 Income Statement
Financials in millions HKD. Fiscal year is April - March.
Millions HKD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2015 - 2019 |
Revenue | 1,295 | 1,393 | 1,389 | 1,350 | 1,090 | 1,241 | Upgrade
|
Revenue Growth (YoY) | -9.98% | 0.29% | 2.91% | 23.88% | -12.18% | 3.67% | Upgrade
|
Cost of Revenue | 475.92 | 499.22 | 503.07 | 441 | 365.08 | 371.1 | Upgrade
|
Gross Profit | 819.54 | 894.12 | 886.19 | 908.97 | 724.69 | 869.85 | Upgrade
|
Selling, General & Admin | 159.03 | 167.76 | 157.23 | 189.22 | 155.79 | 152.89 | Upgrade
|
Other Operating Expenses | 138.38 | 148.8 | 136.56 | 116.91 | 94.77 | 105.2 | Upgrade
|
Operating Expenses | 488.23 | 518.52 | 517.38 | 525.18 | 421.82 | 412.91 | Upgrade
|
Operating Income | 331.31 | 375.6 | 368.81 | 383.79 | 302.87 | 456.94 | Upgrade
|
Interest Expense | -11.16 | -11.22 | -12.52 | -16.1 | -13.14 | -11.9 | Upgrade
|
Interest & Investment Income | 14 | 14.54 | 10.9 | 4.88 | 7.99 | 8.43 | Upgrade
|
Currency Exchange Gain (Loss) | 0.48 | -0.48 | -0.37 | 2 | 5.13 | 0.09 | Upgrade
|
Other Non Operating Income (Expenses) | 0.12 | - | - | 0.18 | 0.11 | 0.17 | Upgrade
|
EBT Excluding Unusual Items | 334.75 | 378.44 | 366.82 | 374.76 | 302.96 | 453.73 | Upgrade
|
Gain (Loss) on Sale of Investments | - | - | - | -3.05 | 1.42 | -1.69 | Upgrade
|
Gain (Loss) on Sale of Assets | -0.62 | -0.47 | -1.1 | 0.13 | -0.47 | -1.46 | Upgrade
|
Other Unusual Items | 5.75 | 5.75 | 25.74 | 6.31 | 54.26 | - | Upgrade
|
Pretax Income | 339.88 | 383.72 | 391.46 | 378.15 | 358.16 | 450.58 | Upgrade
|
Income Tax Expense | 64.53 | 73.32 | 75.82 | 72.91 | 73.53 | 90.42 | Upgrade
|
Earnings From Continuing Operations | 275.35 | 310.4 | 315.64 | 305.25 | 284.63 | 360.16 | Upgrade
|
Minority Interest in Earnings | 14.9 | 5.4 | - | - | - | - | Upgrade
|
Net Income | 290.25 | 315.8 | 315.64 | 305.25 | 284.63 | 360.16 | Upgrade
|
Net Income to Common | 290.25 | 315.8 | 315.64 | 305.25 | 284.63 | 360.16 | Upgrade
|
Net Income Growth | -12.41% | 0.05% | 3.40% | 7.24% | -20.97% | 12.89% | Upgrade
|
Shares Outstanding (Basic) | 1,256 | 1,256 | 1,249 | 1,231 | 1,169 | 1,117 | Upgrade
|
Shares Outstanding (Diluted) | 1,256 | 1,256 | 1,249 | 1,231 | 1,169 | 1,121 | Upgrade
|
Shares Change (YoY) | -0.06% | 0.57% | 1.51% | 5.27% | 4.27% | 0.79% | Upgrade
|
EPS (Basic) | 0.23 | 0.25 | 0.25 | 0.25 | 0.24 | 0.32 | Upgrade
|
EPS (Diluted) | 0.23 | 0.25 | 0.25 | 0.25 | 0.24 | 0.32 | Upgrade
|
EPS Growth | -12.38% | -0.66% | 1.89% | 2.06% | -24.30% | 11.85% | Upgrade
|
Free Cash Flow | 358.3 | 442.94 | 533.83 | 369.34 | 519.64 | 547.92 | Upgrade
|
Free Cash Flow Per Share | 0.28 | 0.35 | 0.43 | 0.30 | 0.45 | 0.49 | Upgrade
|
Dividend Per Share | 0.231 | 0.251 | 0.253 | 0.248 | 0.250 | 0.290 | Upgrade
|
Dividend Growth | -9.41% | -0.79% | 2.02% | -0.80% | -13.79% | 0.35% | Upgrade
|
Gross Margin | 63.26% | 64.17% | 63.79% | 67.33% | 66.50% | 70.09% | Upgrade
|
Operating Margin | 25.57% | 26.96% | 26.55% | 28.43% | 27.79% | 36.82% | Upgrade
|
Profit Margin | 22.41% | 22.66% | 22.72% | 22.61% | 26.12% | 29.02% | Upgrade
|
Free Cash Flow Margin | 27.66% | 31.79% | 38.42% | 27.36% | 47.68% | 44.15% | Upgrade
|
EBITDA | 405.5 | 454.5 | 455.08 | 460.78 | 357.97 | 512.38 | Upgrade
|
EBITDA Margin | 31.30% | 32.62% | 32.76% | 34.13% | 32.85% | 41.29% | Upgrade
|
D&A For EBITDA | 74.19 | 78.9 | 86.26 | 76.99 | 55.1 | 55.44 | Upgrade
|
EBIT | 331.31 | 375.6 | 368.81 | 383.79 | 302.87 | 456.94 | Upgrade
|
EBIT Margin | 25.57% | 26.96% | 26.55% | 28.43% | 27.79% | 36.82% | Upgrade
|
Effective Tax Rate | 18.98% | 19.11% | 19.37% | 19.28% | 20.53% | 20.07% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.